Combined ursodeoxycholic acid (UDCA) and fenofibrate in primary biliary cholangitis patients with incomplete UDCA response may improve outcomes von Cheung, A. C., Lapointe‐Shaw, L., Kowgier, M., Meza‐Cardona, J., Hirschfield, G. M., Janssen, H. L. A., Feld, J. J.

Volltext

Miravirsen dosing in chronic hepatitis C patients results in decreased microRNA‐122 levels without affecting other microRNAs in plasma von Ree, M. H., Meer, A. J., Nuenen, A. C., Bruijne, J., Ottosen, S., Janssen, H. L., Kootstra, N. A., Reesink, H. W.

Volltext

Anticoagulant therapy in patients with non‐cirrhotic portal vein thrombosis: effect on new thrombotic events and gastrointestinal bleeding von Spaander, M. C. W., Hoekstra, J., Hansen, B. E., Buuren, H. R., Leebeek, F. W. G., Janssen, H. L. A.

Volltext

SMAD4 exerts a tumor-promoting role in hepatocellular carcinoma von Hernanda, P Y, Chen, K, Das, A M, Sideras, K, Wang, W, Li, J, Cao, W, Bots, S J A, Kodach, L L, de Man, R A, Ijzermans, J N M, Janssen, H L A, Stubbs, A P, Sprengers, D, Bruno, M J, Metselaar, H J, ten Hagen, T L M, Kwekkeboom, J, Peppelenbosch, M P, Pan, Q

Volltext

Risk factors and outcome of HIV-associated idiopathic noncirrhotic portal hypertension von Schouten, J. N. L., Van der Ende, M. E., Koëter, T., Rossing, H. H. M., Komuta, M., Verheij, J., van der Valk, M., Hansen, B. E., Janssen, H. L. A.

Volltext

Idiopathic noncirrhotic portal hypertension is associated with poor survival: results of a long-term cohort study von Schouten, J. N. L., Nevens, F., Hansen, B., Laleman, W., van den Born, M., Komuta, M., Roskams, T., Verheij, J., Janssen, H. L. A.

Volltext

Insulin Resistance, Serum Adipokines and Risk of Fibrosis Progression in Patients Transplanted for Hepatitis C von Veldt, B. J., Poterucha, J. J., Watt, K. D. S., Wiesner, R. H., Hay, J. E., Rosen, C. B., Heimbach, J. K., Janssen, H. L. A., Charlton, M. R.

Volltext

Hypoxia in head and neck cancer: How much, how important? von Janssen, H. L., Haustermans, K. M., Balm, A. J., Begg, A. C.

Volltext

Sensitive detection of hepatocellular injury in chronic hepatitis C patients with circulating hepatocyte-derived microRNA-122 von van der Meer, A. J., Farid, W. R. R., Sonneveld, M. J., de Ruiter, P. E., Boonstra, A., van Vuuren, A. J., Verheij, J., Hansen, B. E., de Knegt, R. J., van der Laan, L. J. W., Janssen, H. L. A.

Volltext

Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection von van Zonneveld, M., van Nunen, A. B., Niesters, H. G. M., de Man, R. A., Schalm, S. W., Janssen, H. L. A.

Volltext

Randomised clinical trial: anti‐viral activity of ANA773, an oral inducer of endogenous interferons acting via TLR7, in chronic HCV von Bergmann, J. F., de Bruijne, J., Hotho, D. M., de Knegt, R. J., Boonstra, A., Weegink, C. J., van Vliet, A. A., van de Wetering, J., Fletcher, S. P., Bauman, L. A., Rahimy, M., Appleman, J. R., Freddo, J. L., Janssen, H. L. A., Reesink, H. W.

Volltext

Vascular liver disorders (II): portal vein thrombosis von HOEKSTRA, J, JANSSEN, H. L. A

Volltext

HLA-C and KIR combined genotype as new response marker for HBeAg-positive chronic hepatitis B patients treated with interferon-based combination therapy von Stelma, F., Jansen, L., Sinnige, M. J., van Dort, K. A., Takkenberg, R. B., Janssen, H. L. A., Reesink, H. W., Kootstra, N. A.

Volltext

Pregnancy in women with portal vein thrombosis: Results of a multicentric European study on maternal and fetal management and outcome von Hoekstra, J, Seijo, S, Rautou, P.E, Ducarme, G, Boudaoud, L, Luton, D, Alijotas-Reig, J, Casellas-Caro, M, Condat, B, Bresser, E, Thabut, D, Larroque, B, Gárcia-Pagán, J.C, Janssen, H.L.A, Valla, D.C, Plessier, A

Volltext

Exacerbation of chronic hepatitis B infection after delivery von Ter Borg, M. J., Leemans, W. F., De Man, R. A., Janssen, H. L. A.

Volltext

Polymorphisms of HLA‐DP are associated with response to peginterferon in Caucasian patients with chronic hepatitis B von Brouwer, W. P., Sonneveld, M. J., Tabak, F., Simon, K., Cakaloglu, Y., Akarca, U. S., Zeuzem, S., Ferenci, P., Heathcote, J. E., Knegt, R. J., Boonstra, A., Hansen, B. E., Janssen, H. L. A.

Volltext

Review article: long‐term safety of nucleoside and nucleotide analogues in HBV‐monoinfected patients von Lampertico, P., Chan, H. L. Y., Janssen, H. L. A., Strasser, S. I., Schindler, R., Berg, T.

Volltext

Randomised clinical trial: escitalopram for the prevention of psychiatric adverse events during treatment with peginterferon‐alfa‐2a and ribavirin for chronic hepatitis C von de Knegt, R. J., Bezemer, G., Van Gool, A. R., Drenth, J. P. H., Hansen, B. E., Droogleever Fortuyn, H. A., Weegink, C. J., Hengeveld, M. W., Janssen, H. L. A.

Volltext

Prevalence and risk factors for viral blipping in chronic hepatitis B patients treated with nucleos (t) ide analogues von Brahmania, M., Brouwer, W. P., Hansen, T., Mazzulli, T., Feld, J., Wong, D., Kowgier, M., Janssen, H. L. A.

Volltext

Employed family-based genetic discovery combining linkage analysis and exome sequencing to identify RCL1 as a novel candidate gene for depression, with independent replication in a... von Amin, N, de Vrij, F M S, Baghdadi, M, Brouwer, R W W, van Rooij, J G J, Jovanova, O, Uitterlinden, A G, Hofman, A, Janssen, H L A, Murad, S Darwish, Kraaij, R, Stedehouder, J, van den Hout, M C G N, Kros, J M, van IJcken, W F J, Tiemeier, H, Kushner, S A, van Duijn, C M

Volltext